Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Researchers have identified how CBD interacts with cannabinoid receptors to mitigate the negative effects of THC, the psychoactive component of cannabis.

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Scientists have pinpointed a brain circuit that, when activated, reduces anxiety without impairing memory. Using ...

Researchers at CU Anschutz are studying the effect of psychedelic mushrooms on patients with treatment-resistant depression.

Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global population. Researchers have now discovered that opioid delta-receptor agonists may ...

Early dysfunction of the endothelial/blood-brain barrier (BBB) is involved in the pathogenesis of cerebral small vessel disease (SVD), which is a contributor to about 50% of dementias.

New research reveals how CBD and THC interact with brain receptors, unlocking potential for safer cannabis-based treatments.

Naloxone is a fantastic tool in reducing opioid deaths, but gentler versions would be helpful for fighting overdose ...

A new study on brain activity found that heavy cannabis use is linked to reduced activity in memory-related regions, while ...

Neuroscientists at the Sainsbury Wellcome Centre (SWC) at University College London have uncovered a neural mechanism in mice ...

Medical and recreational cannabis use is now legal in many parts of the world, but questions remain about its effect on ...